There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.
We’re watching the largest HIV treatment programme in the world unravelling in real time. We don’t need perfection, but we do need a combination of urgency, action, and strategy to save it, argues Professor Francois Venter.
For centuries, it was believed that tuberculosis spread primarily when a vulnerable person spends hours in a poorly ventilated space with someone infectious. But new findings suggest that much TB transmission also occurs through casual contact. Biénne Huisman reports.
The world desperately needs an effective TB vaccine to reduce the illness and death still being caused by the centuries’ old bacterium. Chris Bateman visited a study site in Paarl where a promising experimental TB vaccine is now being tested as part of a large multi-country clinical trial.
Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working on new long-acting formulations that might, for example, reduce an entire course of TB preventive therapy to a single injection. Catherine Tomlinson reports.
The TB Sustainable Development Goals of reducing incidence and deaths from TB are achievable, if we all work together. We must double down on this ambition and be even bolder in our investments, write Yogan Pillay and Gaurang Tanna.
Just over a month after US President Donald Trump implemented a 90-day freeze of all foreign assistance, the future looks very uncertain for tuberculosis research. Among others, a large TB research programme that was worth up to $200 million was axed last week. Elri Voigt reports.
South Africa faces its worst health crisis in 20 years. Worse than COVID, and one that will overshadow diabetes as a major killer, while pouring petrol on a dwindling TB fire. But it is preventable, argues Professor Francois Venter if our government steps up urgently.
South Africa’s public health system is in turmoil after the widespread cancellation of USAID funding agreements. Among others, a USAID-funded project that helped to keep orphaned children on their HIV medication was forced to close. HIV testing services are also severely impacted in some areas.
Cuts to United States spending on aid and medical research have caused widespread havoc and anxiety in the last month. Professor Tulio de Oliveira sat down with Spotlight’s Biénne Huisman to talk through what it might mean for health research in South Africa.
Despite a waiver on life-saving humanitarian aid, USAID funding for crucial medical services remains frozen. Services remain closed as organisations await approval of revised budgets limited to what is allowed under the waiver. A separate US agency – the Centers for Disease Control and Prevention – restored funding to its beneficiary organisations, allowing them to reopen thanks to a US court judgment.
A US-funded health facility in Pretoria shut its doors for over two weeks after an executive order by President Trump paused funding. A beneficiary of the centre, who is HIV-positive, said that he hadn’t taken his ARVs in roughly two weeks due to the closure. Many were in the same predicament. The health centre reopened on 13 February after funding resumed.
